150 related articles for article (PubMed ID: 31787717)
21. Yokukansan, a traditional Japanese herbal medicine, enhances the anxiolytic effect of fluvoxamine and reduces cortical 5-HT
Ohno R; Miyagishi H; Tsuji M; Saito A; Miyagawa K; Kurokawa K; Takeda H
J Ethnopharmacol; 2018 Apr; 216():89-96. PubMed ID: 29382554
[TBL] [Abstract][Full Text] [Related]
22. Ameliorating effect of Yokukansan on the development of atopic dermatitis-like lesions and scratching behavior in socially isolated NC/Nga mice.
Funakushi N; Yamaguchi T; Jiang J; Imamura S; Kuhara T; Suto H; Ueki R; Kase Y; Kobayashi H; Ogawa H; Ikeda S
Arch Dermatol Res; 2011 Nov; 303(9):659-67. PubMed ID: 21365206
[TBL] [Abstract][Full Text] [Related]
23. Kamishoyosan (a Japanese traditional herbal formula), which effectively reduces the aggressive biting behavior of male and female mice, and potential regulation through increase of Tph1, Tph2, and Esr2 mRNA levels.
Igarashi K; Kuchiiwa T; Kuchiiwa S; Iwai H; Tomita K; Sato T
Brain Res; 2021 Oct; 1768():147580. PubMed ID: 34260963
[TBL] [Abstract][Full Text] [Related]
24. Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters.
Ferris CF; Melloni RH; Koppel G; Perry KW; Fuller RW; Delville Y
J Neurosci; 1997 Jun; 17(11):4331-40. PubMed ID: 9151749
[TBL] [Abstract][Full Text] [Related]
25. Involvement of the benzodiazepine system in the anxiolytic-like effect of Yokukansan (Yi-gan san).
Kamei J; Miyata S; Ohsawa M
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1431-7. PubMed ID: 19647028
[TBL] [Abstract][Full Text] [Related]
26. Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice.
Jiang J; Yamaguchi T; Funakushi N; Kuhara T; Fan PS; Ueki R; Suto H; Kase Y; Ikeda S; Ogawa H
J Dermatol Sci; 2009 Oct; 56(1):37-42. PubMed ID: 19647983
[TBL] [Abstract][Full Text] [Related]
27. Behavioral and pharmacogenetics of aggressive behavior.
Takahashi A; Quadros IM; de Almeida RM; Miczek KA
Curr Top Behav Neurosci; 2012; 12():73-138. PubMed ID: 22297576
[TBL] [Abstract][Full Text] [Related]
28. Anxiolytic effect of a herbal medicine, yokukansan, in aged rats: involvement of serotonergic and dopaminergic transmissions in the prefrontal cortex.
Mizoguchi K; Tanaka Y; Tabira T
J Ethnopharmacol; 2010 Jan; 127(1):70-6. PubMed ID: 19799980
[TBL] [Abstract][Full Text] [Related]
29. Modulation by 5-hT2A receptors of aggressive behavior in isolated mice.
Sakaue M; Ago Y; Sowa C; Sakamoto Y; Nishihara B; Koyama Y; Baba A; Matsuda T
Jpn J Pharmacol; 2002 May; 89(1):89-92. PubMed ID: 12083749
[TBL] [Abstract][Full Text] [Related]
30. Yokukansan inhibits morphine tolerance and physical dependence in mice: the role of α₂A-adrenoceptor.
Nakagawa T; Nagayasu K; Nishitani N; Shirakawa H; Sekiguchi K; Ikarashi Y; Kase Y; Kaneko S
Neuroscience; 2012 Dec; 227():336-49. PubMed ID: 23069764
[TBL] [Abstract][Full Text] [Related]
31. Xiaochaihutang attenuates depressive/anxiety-like behaviors of social isolation-reared mice by regulating monoaminergic system, neurogenesis and BDNF expression.
Ma J; Wang F; Yang J; Dong Y; Su G; Zhang K; Pan X; Ma P; Zhou T; Wu C
J Ethnopharmacol; 2017 Aug; 208():94-104. PubMed ID: 28687505
[TBL] [Abstract][Full Text] [Related]
32.
Hamaguchi T; Tsutsui-Kimura I; F Tanaka K; Mimura M
Nagoya J Med Sci; 2017 Aug; 79(3):351-362. PubMed ID: 28878440
[TBL] [Abstract][Full Text] [Related]
33. Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion.
Katahira H; Sunagawa M; Watanabe D; Kanada Y; Katayama A; Yamauchi R; Takashima M; Ishikawa S; Hisamitsu T
Neuropsychiatr Dis Treat; 2017; 13():863-872. PubMed ID: 28360524
[TBL] [Abstract][Full Text] [Related]
34. Social isolation and expression of serotonergic neurotransmission-related genes in several brain areas of male mice.
Bibancos T; Jardim DL; Aneas I; Chiavegatto S
Genes Brain Behav; 2007 Aug; 6(6):529-39. PubMed ID: 17083332
[TBL] [Abstract][Full Text] [Related]
35. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
36. The Serotonin-Mediated Anti-Allodynic Effect of Yokukansan on Paclitaxel-Induced Neuropathic Pain.
Yokomi H; Kato T; Narasaki S; Kamiya S; Taguchi S; Horikawa YT; Tsutsumi YM
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541085
[TBL] [Abstract][Full Text] [Related]
37. Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients.
Ikarashi Y; Mizoguchi K
Pharmacol Ther; 2016 Oct; 166():84-95. PubMed ID: 27373856
[TBL] [Abstract][Full Text] [Related]
38. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Yokukansan, a traditional Japanese herbal medicine, in patients with dizziness and irritability.
Taki M; Hasegawa T; Ninoyu Y; Hirano S
Auris Nasus Larynx; 2021 Oct; 48(5):864-869. PubMed ID: 33526322
[TBL] [Abstract][Full Text] [Related]
40. Brain region-specific reduction in c-Fos expression associated with an anxiolytic effect of yokukansan in rats.
Shoji H; Mizoguchi K
J Ethnopharmacol; 2013 Aug; 149(1):93-102. PubMed ID: 23770052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
